新型氟化4-喹诺酮衍生物PD 127,391的体外活性比较
Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative.
作者信息
Norrby S R, Jonsson M
机构信息
Department of Infectious Diseases, University of Umeå, Sweden.
出版信息
Antimicrob Agents Chemother. 1988 Aug;32(8):1278-81. doi: 10.1128/AAC.32.8.1278.
Abstract
PD 127,391, a newly developed 4-quinolone chemically similar to ciprofloxacin, was studied in vitro by using agar and broth dilution and two inoculum sizes. PD 127,391 was found to be highly active against gram-negative aerobes, including Pseudomonas aeruginosa and other Pseudomonas spp. Its activity against gram-positive aerobes was better than that of ciprofloxacin.
摘要
PD 127,391是一种新开发的与环丙沙星化学结构相似的4-喹诺酮类药物，采用琼脂稀释法、肉汤稀释法以及两种接种量在体外进行了研究。结果发现，PD 127,391对包括铜绿假单胞菌和其他假单胞菌属在内的革兰氏阴性需氧菌具有高度活性。它对革兰氏阳性需氧菌的活性优于环丙沙星。
相似文献
1
Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative.新型氟化4-喹诺酮衍生物PD 127,391的体外活性比较
Antimicrob Agents Chemother. 1988 Aug;32(8):1278-81. doi: 10.1128/AAC.32.8.1278.
2
[The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem].
Enferm Infecc Microbiol Clin. 2001 Nov;19(9):432-4. doi: 10.1016/s0213-005x(01)72687-0.
3
In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.广谱二氟喹诺酮PD 117596-2的体外活性
Eur J Clin Microbiol Infect Dis. 1989 Jul;8(7):644-50. doi: 10.1007/BF01968149.
4
In-vitro activity of PD 131628, a new quinolone antimicrobial agent.新型喹诺酮抗菌剂PD 131628的体外活性
J Antimicrob Chemother. 1992 May;29(5):519-27. doi: 10.1093/jac/29.5.519.
5
In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.采用标准微量稀释肉汤法和Etest法测定曲伐沙星对需氧敏感菌和耐药菌的体外活性。
J Antimicrob Chemother. 1997 Jun;39 Suppl B:35-42. doi: 10.1093/jac/39.suppl_2.35.
6
In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.磷霉素与头孢他啶、亚胺培南、阿米卡星及环丙沙星联合对铜绿假单胞菌的体外活性
Eur J Clin Microbiol Infect Dis. 1997 Feb;16(2):159-62. doi: 10.1007/BF01709477.
7
The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.新型氟喹诺酮类药物托氟沙星与环丙沙星和替马沙星的体外活性比较。
J Antimicrob Chemother. 1991 Nov;28(5):719-25. doi: 10.1093/jac/28.5.719.
8
The in-vitro activity of PD127,391, a new quinolone.新型喹诺酮类药物PD127,391的体外活性
J Antimicrob Chemother. 1988 Aug;22(2):135-41. doi: 10.1093/jac/22.2.135.
9
In vitro activity of temafloxacin hydrochloride (TA-167 or A-62254), a new fluorinated 4-quinolone.新型氟化4-喹诺酮盐酸替马沙星（TA-167或A-62254）的体外活性
Chemotherapy. 1990;36(5):345-55. doi: 10.1159/000238787.
10
In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains.PD 117,596与对照抗生素对448株临床细菌菌株的体外活性
Antimicrob Agents Chemother. 1988 Sep;32(9):1450-5. doi: 10.1128/AAC.32.9.1450.
引用本文的文献
1
Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.具有7-氮杂环丁烷环取代基的两种新型8-氯氟喹诺酮类化合物E-4767和E-5065的抗菌活性及药代动力学
Antimicrob Agents Chemother. 2001 Nov;45(11):3113-21. doi: 10.1128/AAC.45.11.3113-3121.2001.
2
Comparative activities of clinafloxacin against gram-positive and -negative bacteria.克林沙星对革兰氏阳性菌和阴性菌的比较活性。
Antimicrob Agents Chemother. 1998 May;42(5):1269-73. doi: 10.1128/AAC.42.5.1269.
3
Pharmacokinetics and inflammatory fluid penetration of clinafloxacin.克林沙星的药代动力学和炎性液体渗透情况
Antimicrob Agents Chemother. 1998 Feb;42(2):428-30. doi: 10.1128/AAC.42.2.428.
4
In vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faecium.一种研究性喹诺酮、甘氨环素、糖肽、链阳菌素和恶唑烷酮单独及联合对耐万古霉素屎肠球菌的体外活性。
Antimicrob Agents Chemother. 1997 Nov;41(11):2573-5. doi: 10.1128/AAC.41.11.2573.
5
In vitro activity of HSR-903, a new quinolone.新型喹诺酮HSR-903的体外活性
Antimicrob Agents Chemother. 1997 Jun;41(6):1326-30. doi: 10.1128/AAC.41.6.1326.
6
Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones.四种新型7-氮杂环丁烷基氟喹诺酮类药物的抗菌活性和药代动力学
Antimicrob Agents Chemother. 1996 Jan;40(1):274-7. doi: 10.1128/AAC.40.1.274.
7
New quinolones and gram-positive bacteria.新型喹诺酮类药物与革兰氏阳性菌
Antimicrob Agents Chemother. 1994 Feb;38(2):163-9. doi: 10.1128/AAC.38.2.163.
8
Comparative in vitro activities of new quinolones against coryneform bacteria.新型喹诺酮类药物对棒状杆菌的体外活性比较
Antimicrob Agents Chemother. 1994 Jun;38(6):1439-41. doi: 10.1128/AAC.38.6.1439.
9
Activity of clinafloxacin against multidrug-resistant Enterococcus faecium.克林沙星对耐多药屎肠球菌的活性。
Antimicrob Agents Chemother. 1994 Jul;38(7):1668-70. doi: 10.1128/AAC.38.7.1668.
10
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
本文引用的文献
1
Antibacterial activity of imipenem: the first thienamycin antibiotic.亚胺培南的抗菌活性：首个硫霉素类抗生素。
Rev Infect Dis. 1985 Jul-Aug;7 Suppl 3:S389-410. doi: 10.1093/clinids/7.supplement_3.s389.
2
Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria.第三代头孢菌素及其他新型β-内酰胺类抗生素对临床重要细菌的体外活性综述
Am J Med. 1985 Aug 9;79(2A):14-20. doi: 10.1016/0002-9343(85)90255-4.
3
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.八种新型喹诺酮类药物与萘啶酸的体外活性比较
J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20. doi: 10.1093/jac/18.supplement_d.1.
4
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.喹诺酮类抗菌剂。8-取代喹啉-3-羧酸和1,8-萘啶-3-羧酸的合成及构效关系
J Med Chem. 1988 May;31(5):983-91. doi: 10.1021/jm00400a016.
Zotero 插件